Bifidobacterium bifidum BBi32 and Improved Gut Microbiome Diversity

• Clinical Safety and Tolerability of Bifidobacterium bifidum BBi32: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial With Genomic and In Vitro Corroboration.

  • 2026-01
  • RCT
  • Food science & nutrition 14(1)
  • • Shuguang Fang
    • Shanni Wang
    • Yinhua Liu
    • Chengsheng Zhu
    • Sijia Wang
    • Fei Xu

  • PubMed: 41523287
  • DOI: 10.1002/fsn3.71420

  5 Insights on

  • Improved Gut Microbiome Diversity

  • High evidence

  "Microbiome analysis revealed higher alpha diversity"

  Effect

  Beneficial

  Effect size

  Small